Tumor Cell Lysis
Tumor Cell Lysis - Related Videos
01:32
Tissue Homogenization and Cell Lysis
0 Views •
2023
Tissue homogenization involves disintegrating tissue architecture and lysing cells, and is an early step in isolating and analyzing cellular components. The method used for homogenization depends on the sample type, the amount of sample available, the analyte to be obtained, and the sensitivity of the method. These methods are broadly classified as mechanical and non-mechanical methods. Mechanical methods of tissue homogenization These methods rely on applying external physical force to disrupt...
09:49
A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines
0 Views •
Cited by 1 •
2017
A simple red blood cell lysis method for establishing B-LCLs was developed with high immortalization efficiency, requiring a small amount of blood and saving time from initiation to cryopreservation.
03:12
A Procedure for Bacterial Harvesting and Mechanical Lysis
0 Views •
2025
Source: Mercier, N., et al. MS2-Affinity Purification Coupled with RNA Sequencing in Gram-Positive Bacteria. J. Vis. Exp. (2021)This video demonstrates a step-by-step procedure for harvesting bacterial cells and mechanically lysing them to release intracellular contents.
04:11
Isolation of Endospores from an Environmental Sample by Targeted Lysis of Vegetative Cells
0 Views •
2025
Source: Wunderlin, T., et al. Physical Isolation of Endospores from Environmental Samples by Targeted Lysis of Vegetative Cells. J. Vis. Exp. (2016)This video demonstrates a method to isolate endospores from an environmental sample containing both vegetative cells and various bacteria. The procedure involves filtration, mechanical disruption, and selective chemical treatment to weaken and lyse vegetative cells while preserving endospores. The final step isolates the resilient endospores through...
09:53
Automated Microfluidic Blood Lysis Protocol for Enrichment of Circulating Nucleated Cells
0 Views •
Cited by 4 •
2009
An automated microfluidic device was developed for circulating nucleated cell enrichment from peripheral blood via erythrocyte lysis that ensures isolation of high quality sample without cell loss.
FAQs
Cytotoxic T lymphocytes and natural killer cells can activate programmed cell death in malignant cells, rather than relying only on direct physical disruption. This distinction is important because immune surveillance depends on recognizing and eliminating abnormal cells through effector-cell activity. Studying the resulting loss of viable tumor cells helps assess how effectively host immune defenses act against cancer.
Antibodies can direct immune activity toward tumor cells, while complement proteins can contribute to membrane disruption. These mechanisms represent distinct routes to loss of cellular integrity and can be examined separately when evaluating immune-mediated cytotoxicity. Their effects are especially relevant in studies of antibody-dependent cytotoxicity and complement activity against malignant tissue.
Lysis can release tumor-associated antigens from damaged cells. Those antigens may influence subsequent immune responses, linking the initial destruction of malignant tissue with later stages of immune recognition or activation. Consequently, tumor cell lysis is relevant not only as an outcome that reduces tumor burden but also as a process that can shape ongoing host defense.
In infection-focused research, tumor cell lysis provides a way to examine interactions among pathogens, immune cells, and malignant tissue. The process can therefore serve as a readout of how host-defense mechanisms operate in a setting where infection and cancer biology intersect. This context broadens analysis beyond isolated tumor cells or conventional anticancer treatment responses.
Measuring the extent of tumor cell lysis helps researchers evaluate whether an immunotherapy produces effective malignant-cell destruction. The measurement can be used to examine immune effector activity and the resulting reduction in tumor burden. It also supports comparisons among approaches that depend on cytotoxic lymphocytes, antibodies, complement proteins, or other therapeutic agents.
Tumor cell lysis is used to assess immunotherapies, antibody-dependent cytotoxicity, complement activity, and interactions involving infection and malignant tissue. In each application, the outcome indicates whether cancer-cell integrity has been lost through the mechanism under study. This makes lysis a practical endpoint for connecting immune or therapeutic activity with effects on tumor cells.